Atai Beckley-Lilly merger clears US antitrust waiting period

Reuters2026/08/31 20:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Eli Lilly plans to acquire Atai Beckley via a merger, leaving Atai Beckley as a wholly owned Lilly subsidiary.
The U.S. antitrust waiting period tied to the deal expired at 11:59 p.m. ET on Aug. 28, 2026.
UK competition officials indicated on Aug. 21, 2026 they had no further questions on the transaction.
Australia’s competition regulator cleared the deal subject to a 14-day waiting period set to end at 10:00 a.m. ET on Sept. 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atai Beckley Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-035091), on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Atai Beckley-Lilly merger clears US antitrust waiting period

You may also like

Crypto prices